Cargando…

异基因造血干细胞移植中非血缘供者KIR2DL1、KIR3DL1免疫重建规律的研究

OBJECTIVE: To investigate the immune reconstruct regularity profile of KIR2DL1 and KIR3DL1 in unrelated-donor allogeneic hematopoietic stem cell transplantation (allo-HSCT) with KIR-AA genotype. METHODS: 75 donor-recipient pairs were performed by KIR genotying using PCR-SSP, and all donors were iden...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial office of Chinese Journal of Hematology 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348245/
https://www.ncbi.nlm.nih.gov/pubmed/28954344
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2017.08.004
_version_ 1783556761315180544
collection PubMed
description OBJECTIVE: To investigate the immune reconstruct regularity profile of KIR2DL1 and KIR3DL1 in unrelated-donor allogeneic hematopoietic stem cell transplantation (allo-HSCT) with KIR-AA genotype. METHODS: 75 donor-recipient pairs were performed by KIR genotying using PCR-SSP, and all donors were identified with KIR-AA genotype. Dynamic detections (including unrelated-donor on the day of transplantation and the recipient each month post allo-HSCT) of the expression of KIR2DL1/3DL1 on NK cell and mRNA level were performed in 291 cases using flow cytometry (FCM) and real-time fluorescent quantitation PCR (RT-qPCR). RESULT: ①The median expression of KIR2DL1 in unrelated-donor on transplant's day was 21.60%, the median expression of KIR2DL1 in recipient 1M, 2M, 3M and 3–6M after transplantation were 7.40%, 12.00%, 16.92%, 17.64% respectively. The median expression of KIR2DL1 in unrelated-donor on transplant's day was 265.14 copies/10 000abl copies, the median expression of KIR2DL1 in recipient 1M, 2M, 3M, 3–6M, 6–9M, 9–12M after transplantation were 332.17, 438.31, 723.25, 414.17, 180.76 and 234.67 copies/10 000abl copies respectively. The median expression of KIR2DL1 on NK cells and mRNA level gradually increased at all time points after transplantation, and reached the highest expression at 3 months after transplantation. But mRNA expression levels increased earlier than NK cell membrane proteins. ②The median expression of KIR3DL1 in unrelated-donors on transplant's day was 18.56%, the median expression of KIR3DL1 in recipient 1M, 2M, 3M, 3–6M after transplantation were 23.83%, 22.57%, 23.02%, 21.60% respectively. The median expression of KIR3DL1 in unrelated-donor on transplant's day was 572.29 copies/10 000abl copies, the median expression of KIR3DL1 in recipient 1M, 2M, 3M, 3–6M, 6–9M, 9–12M after transplantation were 1 233.74, 1 140.42, 876.73, 1 057.07, 739.02 and 514.43 copies/10 000abl copies respectively. The median expression of KIR3DL1 on NK cells and mRNA level were higher than donors at 1 month after transplantation, and stable expression at all time points after transplantation, so mRNA and NK cell membrane proteins expression increased at the same time. CONCLUSION: The immune reconstruct regularity of KIR2DL1 and KIR3DL1 gene were different, which provided an experimental basis for selecting the best time to detect the expressions of KIR2DL1 and 3DL1 after transplantation.
format Online
Article
Text
id pubmed-7348245
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Editorial office of Chinese Journal of Hematology
record_format MEDLINE/PubMed
spelling pubmed-73482452020-07-16 异基因造血干细胞移植中非血缘供者KIR2DL1、KIR3DL1免疫重建规律的研究 Zhonghua Xue Ye Xue Za Zhi 论著 OBJECTIVE: To investigate the immune reconstruct regularity profile of KIR2DL1 and KIR3DL1 in unrelated-donor allogeneic hematopoietic stem cell transplantation (allo-HSCT) with KIR-AA genotype. METHODS: 75 donor-recipient pairs were performed by KIR genotying using PCR-SSP, and all donors were identified with KIR-AA genotype. Dynamic detections (including unrelated-donor on the day of transplantation and the recipient each month post allo-HSCT) of the expression of KIR2DL1/3DL1 on NK cell and mRNA level were performed in 291 cases using flow cytometry (FCM) and real-time fluorescent quantitation PCR (RT-qPCR). RESULT: ①The median expression of KIR2DL1 in unrelated-donor on transplant's day was 21.60%, the median expression of KIR2DL1 in recipient 1M, 2M, 3M and 3–6M after transplantation were 7.40%, 12.00%, 16.92%, 17.64% respectively. The median expression of KIR2DL1 in unrelated-donor on transplant's day was 265.14 copies/10 000abl copies, the median expression of KIR2DL1 in recipient 1M, 2M, 3M, 3–6M, 6–9M, 9–12M after transplantation were 332.17, 438.31, 723.25, 414.17, 180.76 and 234.67 copies/10 000abl copies respectively. The median expression of KIR2DL1 on NK cells and mRNA level gradually increased at all time points after transplantation, and reached the highest expression at 3 months after transplantation. But mRNA expression levels increased earlier than NK cell membrane proteins. ②The median expression of KIR3DL1 in unrelated-donors on transplant's day was 18.56%, the median expression of KIR3DL1 in recipient 1M, 2M, 3M, 3–6M after transplantation were 23.83%, 22.57%, 23.02%, 21.60% respectively. The median expression of KIR3DL1 in unrelated-donor on transplant's day was 572.29 copies/10 000abl copies, the median expression of KIR3DL1 in recipient 1M, 2M, 3M, 3–6M, 6–9M, 9–12M after transplantation were 1 233.74, 1 140.42, 876.73, 1 057.07, 739.02 and 514.43 copies/10 000abl copies respectively. The median expression of KIR3DL1 on NK cells and mRNA level were higher than donors at 1 month after transplantation, and stable expression at all time points after transplantation, so mRNA and NK cell membrane proteins expression increased at the same time. CONCLUSION: The immune reconstruct regularity of KIR2DL1 and KIR3DL1 gene were different, which provided an experimental basis for selecting the best time to detect the expressions of KIR2DL1 and 3DL1 after transplantation. Editorial office of Chinese Journal of Hematology 2017-08 /pmc/articles/PMC7348245/ /pubmed/28954344 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2017.08.004 Text en 2017年版权归中华医学会所有 http://creativecommons.org/licenses/by-nc-sa/3.0/ This work is licensed under a Creative Commons Attribution 3.0 License (CC-BY-NC). The Copyright own by Publisher. Without authorization, shall not reprint, except this publication article, shall not use this publication format design. Unless otherwise stated, all articles published in this journal do not represent the views of the Chinese Medical Association or the editorial board of this journal.
spellingShingle 论著
异基因造血干细胞移植中非血缘供者KIR2DL1、KIR3DL1免疫重建规律的研究
title 异基因造血干细胞移植中非血缘供者KIR2DL1、KIR3DL1免疫重建规律的研究
title_full 异基因造血干细胞移植中非血缘供者KIR2DL1、KIR3DL1免疫重建规律的研究
title_fullStr 异基因造血干细胞移植中非血缘供者KIR2DL1、KIR3DL1免疫重建规律的研究
title_full_unstemmed 异基因造血干细胞移植中非血缘供者KIR2DL1、KIR3DL1免疫重建规律的研究
title_short 异基因造血干细胞移植中非血缘供者KIR2DL1、KIR3DL1免疫重建规律的研究
title_sort 异基因造血干细胞移植中非血缘供者kir2dl1、kir3dl1免疫重建规律的研究
topic 论著
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348245/
https://www.ncbi.nlm.nih.gov/pubmed/28954344
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2017.08.004
work_keys_str_mv AT yìjīyīnzàoxuègànxìbāoyízhízhōngfēixuèyuángōngzhěkir2dl1kir3dl1miǎnyìzhòngjiànguīlǜdeyánjiū
AT yìjīyīnzàoxuègànxìbāoyízhízhōngfēixuèyuángōngzhěkir2dl1kir3dl1miǎnyìzhòngjiànguīlǜdeyánjiū
AT yìjīyīnzàoxuègànxìbāoyízhízhōngfēixuèyuángōngzhěkir2dl1kir3dl1miǎnyìzhòngjiànguīlǜdeyánjiū
AT yìjīyīnzàoxuègànxìbāoyízhízhōngfēixuèyuángōngzhěkir2dl1kir3dl1miǎnyìzhòngjiànguīlǜdeyánjiū
AT yìjīyīnzàoxuègànxìbāoyízhízhōngfēixuèyuángōngzhěkir2dl1kir3dl1miǎnyìzhòngjiànguīlǜdeyánjiū
AT yìjīyīnzàoxuègànxìbāoyízhízhōngfēixuèyuángōngzhěkir2dl1kir3dl1miǎnyìzhòngjiànguīlǜdeyánjiū
AT yìjīyīnzàoxuègànxìbāoyízhízhōngfēixuèyuángōngzhěkir2dl1kir3dl1miǎnyìzhòngjiànguīlǜdeyánjiū
AT yìjīyīnzàoxuègànxìbāoyízhízhōngfēixuèyuángōngzhěkir2dl1kir3dl1miǎnyìzhòngjiànguīlǜdeyánjiū
AT yìjīyīnzàoxuègànxìbāoyízhízhōngfēixuèyuángōngzhěkir2dl1kir3dl1miǎnyìzhòngjiànguīlǜdeyánjiū